Clinical Activity and Tolerability of a 14-Day Infusional Ifosfamide Schedule in Soft-Tissue Sarcoma

Table 1

Patient characteristics.

Total	35
Age (median, range)	53 (27–76)
	𝑛 (%)
Sex
Male	16 (45.7%)
Female	19 (54.3%)
ECOG performance status at baseline
0	1 (2.8%)
1	30 (85.7%)
2	4 (11.4%)
Histology
De-differentiated liposarcoma	22 (62.8%)
Synovial sarcoma	7 (20%)
Myxoid/round-cell liposarcoma	3 (8.5%)
Other	3 (8.5%)
Previous chemotherapy
Chemotherapy naive	23 (65.7%)
Ifosfamide-containing regimen	9 (25.7%)
Nonifosfamide-containing regimen	3 (8.5%)
Previous surgery
Yes	23 (65.7%)
No	12 (34.3%)
Baseline creatinine clearance; (Cockroft-Gault formula)
Median	97 mL/min; (51.9–215.8)
Baseline albumin
Median	35 g/L (21–43)